- Home
- Products
- Customized FluoroAb™
- CA6
- Anti-CA6 MAb (Clone 1)-iFluor® 350 Succinimidyl Ester
Anti-CA6 MAb (Clone 1)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS470)
This product is comprised of an Anti-MUC1 Antibody (Clone 1) labeled with iFluor® 350 Succinimidyl Ester. iFluor® 350 Succinimidyl Ester is a Blue-fluorescent dye and it's excitation/emission is 345/450 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- CA6
- Overview
- Anti-MUC1 Antibody (Clone 1)
- Species Reactivity
- Human
- Name
- iFluor® 350 Succinimidyl Ester
- Color
- Blue
- Excitation⁄Emission (nm)
- 345/450
- Detection method
- Fluorescent
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS470. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-469 | Anti-CA6-SPDB-DM4 ADC | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-CD33 MAb (Clone 10)-iFluor® 488 Succinimidyl Ester (CAT#: WJY0-LS10094)
- Anti-CD80 MAb (Clone 3)-iFluor® 532 Succinimidyl Ester (CAT#: WJY0-LS13525)
- Anti-HBV surface antigen MAb (Clone 2)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS9250)
- Anti-ERBB2 MAb (Clone 25)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS11320)
- Anti-CD74 MAb (Clone 7)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS7007)
- Anti-MET MAb (Clone 27)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS15262)
- Anti-CD3E MAb (Clone 10)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS1127)
- Anti-CD19 MAb (Clone 32)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2476)
- Anti-ITGB2 MAb (Clone 4)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS4452)
- Siplizumab-iFluor 532 (CAT#: ADC-FL-400)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
